Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
0.4948
+0.0237 (5.03%)
At close: Jun 26, 2026, 4:00 PM EDT
0.4998
+0.0050 (1.01%)
After-hours: Jun 26, 2026, 7:49 PM EDT
Genprex Market Cap
Genprex has a market cap or net worth of $5.24 million as of June 26, 2026. Its market cap has decreased by -39.09% in one year.
Market Cap
5.24M
Enterprise Value
-12.81M
1-Year Change
-39.09%
Ranking
Category
Stock Price
$0.49
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.30M to $5.24M, a decrease of -53.64%. That is a compound annual growth rate of -8.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 5.20M | 30.00% |
| Dec 31, 2025 | 4.00M | -44.44% |
| Dec 31, 2024 | 7.20M | -47.45% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.18% |
| Dec 31, 2021 | 62.60M | -61.92% |
| Dec 31, 2020 | 164.40M | 3,123.53% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 46.90% |
| Mar 29, 2018 | 11.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adial Pharmaceuticals | 5.53M |
| PMGC Holdings | 5.27M |
| Processa Pharmaceuticals | 5.20M |
| Mustang Bio | 5.08M |
| Alaunos Therapeutics | 5.01M |
| Alzamend Neuro | 4.91M |
| CollPlant Biotechnologies | 4.90M |
| Enveric Biosciences | 4.71M |